STOCK TITAN

BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
BIMI Holdings Inc. (NASDAQ: BIMI) received a delinquency compliance alert notice from Nasdaq due to the late filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Nasdaq granted the Company 60 days to submit a plan to regain compliance with the Rule. The Company plans to submit its compliance plan by June 18, 2024, potentially extending the deadline to October 14, 2024.
BIMI Holdings Inc. (NASDAQ: BIMI) ha ricevuto un avviso di inadempienza da Nasdaq a causa del ritardo nella presentazione del suo rapporto annuale su modulo 10-K per l'anno fiscale conclusosi il 31 dicembre 2023. Nasdaq ha concesso alla società 60 giorni per presentare un piano per riacquisire la conformità con la regola. La società prevede di inviare il suo piano di conformità entro il 18 giugno 2024, estendendo potenzialmente la scadenza al 14 ottobre 2024.
BIMI Holdings Inc. (NASDAQ: BIMI) recibió una notificación de incumplimiento de Nasdaq debido a la presentación tardía de su Informe Anual en el Formulario 10-K para el año fiscal que terminó el 31 de diciembre de 2023. Nasdaq otorgó a la compañía 60 días para presentar un plan para recuperar el cumplimiento con la norma. La compañía planea enviar su plan de cumplimiento antes del 18 de junio de 2024, lo que podría extender el plazo hasta el 14 de octubre de 2024.
BIMI 홀딩스 인크(NASDAQ: BIMI)는 2023년 12월 31일에 끝난 회계 연도의 연례 보고서 양식 10-K를 늦게 제출했다는 이유로 나스닥으로부터 이행 지연 경고 통지를 받았습니다. 나스닥은 회사에 규칙 준수를 회복하기 위한 계획을 제출할 수 있는 60일을 부여했습니다. 회사는 2024년 6월 18일까지 준수 계획을 제출할 계획이며, 이로 인해 마감 기한이 2024년 10월 14일까지 연장될 수 있습니다.
BIMI Holdings Inc. (NASDAQ: BIMI) a reçu une notification de non-conformité de Nasdaq due au dépôt tardif de son rapport annuel sur le formulaire 10-K pour l'exercice clos le 31 décembre 2023. Nasdaq a accordé à l'entreprise 60 jours pour soumettre un plan afin de retrouver la conformité avec la règle. L'entreprise prévoit de soumettre son plan de conformité d'ici le 18 juin 2024, ce qui pourrait repousser la date limite au 14 octobre 2024.
BIMI Holdings Inc. (NASDAQ: BIMI) hat aufgrund der verspäteten Einreichung seines Jahresberichts auf Formular 10-K für das am 31. Dezember 2023 beendete Geschäftsjahr eine Benachrichtigung über Nichteinhaltung von Nasdaq erhalten. Nasdaq gewährte dem Unternehmen 60 Tage Zeit, um einen Plan zur Wiedererlangung der Regelkonformität vorzulegen. Das Unternehmen plant, seinen Konformitätsplan bis zum 18. Juni 2024 einzureichen, wodurch sich die Frist möglicherweise bis zum 14. Oktober 2024 verlängert.
Positive
  • None.
Negative
  • None.

The notice received by BIMI from Nasdaq concerning filing delinquency is a red flag for potential investors as it reflects on the company's ability to meet regulatory requirements. Delays in filing annual reports can suggest underlying issues such as operational inefficiencies, potential financial restatements, or more serious financial troubles. This can also lead to heightened volatility in the company's stock as markets react to uncertainty. Investors should monitor the company's ability to formulate and execute a timely plan of compliance, as failure to regain compliance may result in delisting, which substantially impacts liquidity and share valuation.

From a legal standpoint, BIMI's failure to file its annual report within the stipulated time frame contravenes Nasdaq's Listing Rule 5250(c)(1). This rule is pivotal to ensuring that listed companies maintain a minimum level of transparency and regularity in financial reporting, which is important for investor trust. The 60-day window to submit a compliance plan is the company's immediate lifeline to rectify the breach. Investors should be aware that the outcome of the appeal process, if it comes to that, can be unpredictable. Moreover, the legal ramifications of delisting extend beyond immediate stock performance concerns; the company's ability to attract future financing and enter partnerships could be adversely affected.

New York, April 23, 2024 (GLOBE NEWSWIRE) --  BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on April 19, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC.

Nasdaq provided the Company 60 days to submit a plan to regain compliance with the Rule (the “Plan”).  The Company intends to submit its plan of compliance to Nasdaq by June 18, 2024. If Nasdaq accepts the Plan, the Company may be granted an extension of 180 calendar days from the due date of the Form 10-K, or until October 14, 2024, to regain compliance with the Rule. In the event the Plan is not accepted by Nasdaq, the Company may appeal that decision to a Hearings Panel.

About BIMI Holdings Inc.
BIMI Holdings Inc. is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. For more information, please visit usbimi.com.

Forward-Looking Statements
This announcement contains forward-looking statements as defined under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, formulated in accordance with the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. These statements, reflecting the Company's projections about its future financial and operational performance, employ terms like 'believes,' 'estimates,' 'anticipates,' 'expects,' 'plans,' 'projects,' 'intends,' 'potential,' 'target,' 'aim,' 'predict,' 'outlook,' 'seek,' 'goal,' 'objective,' 'assume,' 'contemplate,' 'continue,' 'positioned,' 'forecast,' 'likely,' 'may,' 'could,' 'might,' 'will,' 'should,' 'approximately,' and similar expressions to convey the uncertainty of future events or outcomes. These forward-looking statements are based on the Company's current expectations, assumptions, and projections, involving judgments about future economic conditions, competitive landscapes, market dynamics, and business decisions, many of which are inherently challenging to predict accurately and are largely beyond the Company's control. Additionally, these statements are subject to a multitude of known and unknown risks, uncertainties, and other variables that could significantly diverge the Company's actual results from those depicted in any forward-looking statement. These factors include, but are not limited to, varying economic conditions, competitive pressures, and regulatory changes. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, the Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Investor Relations Contact
Investor Relations Department of BIMI Holdings Inc.
Email: vinson@usbimi.com
Tel: +1 949 981 6274


FAQ

Why did BIMI Holdings Inc. receive a delinquency compliance alert notice from Nasdaq?

BIMI Holdings Inc. received a delinquency compliance alert notice from Nasdaq due to the late filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

What is the deadline for BIMI Holdings Inc. to submit a plan to regain compliance with the Rule?

BIMI Holdings Inc. has 60 days from the receipt of the notice to submit a plan to regain compliance with the Rule.

When does BIMI Holdings Inc. plan to submit its compliance plan to Nasdaq?

BIMI Holdings Inc. plans to submit its compliance plan to Nasdaq by June 18, 2024.

What is the potential extension deadline for BIMI Holdings Inc. to regain compliance with the Rule?

If Nasdaq accepts the Plan, BIMI Holdings Inc. may have an extension of 180 calendar days from the due date of the Form 10-K, potentially until October 14, 2024.

BIMI International Medical Inc.

NASDAQ:BIMI

BIMI Rankings

BIMI Latest News

BIMI Stock Data

15.54M
2.77M
76.62%
0.1%
0.12%
Iron and Steel Forging
Manufacturing
Link
United States of America
NEW YORK

About BIMI

bimi international medical inc. (nasdaq: bimi) is an american multinational healthcare products and services provider, offering a broad range of healthcare products and related services. the company currently operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. the wholesale pharmaceuticals segment includes supplying prescription and otc medicines, traditional chinese medicines (“tcm”), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. the wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. medical services include private comprehensive hospitals operating in china. the retail pharmacy segment sells prescription and otc medicines, tcm, healthcare supplies and sundry items to retail customers through its directly-owned pharmacies a